cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Organon Co
57 own
7 watching
Current Price
$29.76
$-0.65
(-2.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
7,569.87M
52-Week High
52-Week High
39.475
52-Week Low
52-Week Low
22.88
Average Volume
Average Volume
1.03M
Dividend Yield
Dividend Yield
0.007718
P/E Ratio
P/E Ratio
--
iconMarket Capitalization7,569.87M
icon52-Week High39.475
icon52-Week Low22.88
iconAverage Volume1.03M
iconDividend Yield0.007718
iconP/E Ratio--
What does the Organon Co do?
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women s health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.
Read More
How much money does Organon Co make?
News & Events about Organon Co.
Business Wire
30days ago
Organon (NYSE: OGN), a global womens healthcare company, today announced a strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy. The agreement also grants Organon...
Globe Newswire
1month ago
DARE-PDM1 Utilizes Proprietary Hydrogel Technology for Vaginal Delivery of Diclofenac, a Nonsteroidal Anti-Inflammatory; Phase 1 Study Targeted for 2023 2022 Dar Portfolio Accomplishments Include: Two Additional Portfolio Programs (DARE-GML and grant-funded DARE-LBT); License Agreement with Organon ...
Business Wire
1month ago
Organon (NYSE: OGN), a global womens healthcare company, today announced that Kirke Weaver has been appointed General Counsel and Corporate Secretary, and will continue as a member of Organons executive leadership team, effective January 1, 2023. Mr. Weaver was named as the interim head of the...
Ticker Report
3 months ago
ProShare Advisors LLC reduced its position in shares of Organon Co. (NYSE:OGN Get Rating) by 22.5% in the 2nd quarter, according to its most recent disclosure with the Securities Exchange Commission. The institutional investor owned 55,771 shares of the companys stock ...
PR Newswire
4 months ago
Organon and Flat6Labs Announce Winners of MENA Region's First Digital-Health FemTech Accelerator Organon and Flat6Labs Announce Winners of MENA Region's First Digital-Health FemTech Accelerator PR Newswire CAIRO, Sept. 13, 2022 - 'Omgyno' founded by Doreen Toutikian and Elisabeth Milini in Greece...
Frequently Asked Questions
Frequently Asked Questions
What is Organon Co share price today?
plus_minus_icon
Can Indians buy Organon Co shares?
plus_minus_icon
How can I buy Organon Co shares from India?
plus_minus_icon
Can Fractional shares of Organon Co be purchased?
plus_minus_icon
What are the documents required to start investing in Organon Co stocks?
plus_minus_icon
What is today’s traded volume of Organon Co?
plus_minus_icon
What is today’s market capitalisation of Organon Co?
plus_minus_icon
What is the 52-Week High and Low Range of Organon Co?
plus_minus_icon
What percentage is Organon Co down from its 52-Week High?
plus_minus_icon
What percentage is Organon Co up from its 52-Week Low?
plus_minus_icon
Current Price
$29.76
$-0.65
(-2.14%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00